Clinical Trial Update: Ocular Surface Syndrome Post-lasik, Outcomes of Treatment With Platelet Rich Plasma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating platelet-rich plasma for ocular surface syndrome with dry eye after LASIK. The study reports outcomes from treating post-LASIK d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Ocular Surface Disease

Drugs mentioned

• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Vissum, Instituto Oftalmológico de Alicante | Conditions: Dry Eye After LASIK-Laser in Situ Keratomileusis | Phase 2 | Status: COMPLETED